{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:19:59Z","timestamp":1784330399716,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UNAM-PAPIIT","award":["IN207121"],"award-info":[{"award-number":["IN207121"]}]},{"name":"UNAM-PAPIIT","award":["IN206619"],"award-info":[{"award-number":["IN206619"]}]},{"DOI":"10.13039\/501100010292","name":"Fundaci\u00f3n Miguel Alem\u00e1n, A.C.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sepsis is a syndrome where the dysregulated host response to infection threatens the life of the patient. The isoform of the cholesteryl-ester transfer protein (CETPI) is synthesized in the small intestine, and it is present in human plasma. CETPI and peptides derived from its C-terminal sequence present the ability to bind and deactivate bacterial lipopolysaccharides (LPS). The present study establishes the relationship between the plasma levels of CETPI and disease severity of sepsis due to Gram-negative bacteria.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Plasma samples from healthy subjects and patients with positive blood culture for Gram-negative bacteria were collected at the Intensive Care Unit (ICU) of INCMNSZ (Mexico City). 47 healthy subjects, 50 patients with infection, and 55 patients with sepsis and septic shock, were enrolled in this study. CETPI plasma levels were measured by an enzyme-linked immunosorbent assay and its expression confirmed by Western Blot analysis. Plasma cytokines (IL-1\u03b2, TNF\u03b1, IL-6, IL-8, IL-12p70, IFN\u03b3,\u00a0and IL-10) were measured in both, healthy subjects, and patients, and directly correlated with their CETPI plasma levels and severity of clinical parameters. Sequential Organ Failure Assessment (SOFA) scores were evaluated at ICU admission and within 24\u00a0h of admission. Plasma LPS and CETPI levels were also measured and studied in patients \u00a0with liver dysfunction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The level of CETPI in plasma was found to be higher in patients with positive blood culture for Gram-negative bacteria that in control subjects, showing a direct correlation with their SOFA values. Accordingly, septic shock patients showing a high CETPI plasma concentration, presented a negative correlation with cytokines IL-8, IL-1\u03b2, and IL-10. Also, in patients \u00a0with liver dysfunction, since higher CETPI levels correlated with a high plasma LPS concentration, LPS neutralization carried out by CETPI might be considered a physiological response that will have to be studied in detail.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Elevated levels of plasma CETPI were associated with disease severity and organ failure in patients \u00a0with Gram-negative bacteraemia, defining CETPI as a protein implicated in the systemic response to LPS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-022-00585-3","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T20:22:43Z","timestamp":1671481363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The cholesteryl-ester transfer protein isoform (CETPI) and derived peptides: new targets in the study of Gram-negative sepsis"],"prefix":"10.1186","volume":"28","author":[{"given":"Er\u00e9ndira G.","family":"P\u00e9rez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"De la Puente-D\u00edaz de Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Luna-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Delgado-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Sifuentes-Osornio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8007-6993","authenticated-orcid":false,"given":"Jaime","family":"Mas-Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"585_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1023\/A:1022832531473","volume":"245","author":"AL Alonso","year":"2003","unstructured":"Alonso AL, Zentella-Dehesa A, Mas-Oliva J. Characterization of a naturally occurring new version of the cholesterol ester transfer protein (CETP) from small intestine. Mol Cell Biochem. 2003;245:173\u201382.","journal-title":"Mol Cell Biochem"},{"key":"585_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13054-019-2684-2","volume":"23","author":"BJ Anderson","year":"2019","unstructured":"Anderson BJ, Calfee CS, Liu KD, Reilly JP, Kangelaris KN, Shashaty MGS, et al. Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study. Crit Care. 2019;23:400.","journal-title":"Crit Care"},{"key":"585_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1471-2180-10-172","volume":"10","author":"T Angrisano","year":"2010","unstructured":"Angrisano T, Pero R, Peluso S, Keller S, Sacchetti S, Bruni CB, et al. LPS-induced IL-8 activation in human intestinal epithelial cells is accompanied by specific histone H3 acetylation and methylation changes. BMC Microbiol. 2010;10:172.","journal-title":"BMC Microbiol"},{"key":"585_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13054-021-03862-5","volume":"26","author":"T Barichello","year":"2022","unstructured":"Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review. Crit Care. 2022;26:14.","journal-title":"Crit Care"},{"key":"585_CR5","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.bja.2018.05.072","volume":"121","author":"J Bauz\u00e1-Mart\u00ednez","year":"2018","unstructured":"Bauz\u00e1-Mart\u00ednez J, Aletti F, Pinto BB, Ribas V, Odena MA, D\u00edaz R, et al. Proteolysis in septic shock patients: plasma peptidomic patterns are associated with mortality. Br J Anaesth. 2018;121:1065\u201374.","journal-title":"Br J Anaesth"},{"key":"585_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1042\/bst0310791","volume":"31","author":"LJ Beamer","year":"2003","unstructured":"Beamer LJ. Structure of human BPI (bactericidal\/permeability-increasing protein) and implications for related proteins. Biochem Soc Trans. 2003;31:791\u20134.","journal-title":"Biochem Soc Trans"},{"key":"585_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0168-8278(87)80003-X","volume":"4","author":"C Bode","year":"1987","unstructured":"Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 1987;4:8\u201314.","journal-title":"J Hepatol"},{"key":"585_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. The Lancet. 2018;392:75\u201387.","journal-title":"The Lancet"},{"key":"585_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cca.2016.07.002","volume":"460","author":"SL Fan","year":"2016","unstructured":"Fan SL, Miller NS, Lee J, Remick DG. Diagnosing sepsis\u2014the role of laboratory medicine. Clin Chim Acta. 2016;460:203\u201310.","journal-title":"Clin Chim Acta"},{"key":"585_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.mcna.2020.02.011","volume":"104","author":"MD Font","year":"2020","unstructured":"Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock\u2014basics of diagnosis, pathophysiology and clinical decision making. Med Clin North Am. 2020;104:573\u201385.","journal-title":"Med Clin North Am"},{"key":"585_CR11","doi-asserted-by":"publisher","first-page":"16091","DOI":"10.1038\/srep16091","volume":"5","author":"V Garc\u00eda-Gonz\u00e1lez","year":"2015","unstructured":"Garc\u00eda-Gonz\u00e1lez V, Guti\u00e9rrez-Quintanar N, Mas-Oliva J. The C-terminal domain supports a novel function for CETPI as a new plasma lipopolysaccharide-binding protein. Sci Rep. 2015;5:16091.","journal-title":"Sci Rep"},{"key":"585_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BST20190029","volume":"48","author":"I Grondman","year":"2020","unstructured":"Grondman I, Pirvu A, Riza A, Ioana M, Netea MG. Biomarkers of inflammation and the etiology of sepsis. Biochem Soc Trans. 2020;48:1\u201314.","journal-title":"Biochem Soc Trans"},{"key":"585_CR13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1042\/BST0391039","volume":"39","author":"BC Krasity","year":"2011","unstructured":"Krasity BC, Troll JV, Weiss JP, McFall-Ngai MJ. LBP\/BPI proteins and their relatives: conservation over evolution and roles in mutualism. Biochem Soc Trans. 2011;39:1039\u201344.","journal-title":"Biochem Soc Trans"},{"key":"585_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","volume":"23","author":"S Lambden","year":"2019","unstructured":"Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score\u2014development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23:374.","journal-title":"Crit Care"},{"key":"585_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.gpb.2019.08.002","volume":"18","author":"F Li","year":"2020","unstructured":"Li F, Leier A, Liu Q, Wang Y, Xiang D, Akutsu T, et al. Procleave: predicting protease-specific substrate cleavage sites by combining sequence and structural information. Genomics Proteomics Bioinformatics. 2020;18:52\u201364.","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"585_CR16","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.cellsig.2005.12.001","volume":"18","author":"YW Liu","year":"2006","unstructured":"Liu YW, Chen CC, Tseng HP, Chang WC. Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-\u03baB-induced CCAAT\/enhancer-binding protein \u03b4 in mouse macrophages. Cell Signal. 2006;18:1492\u2013500.","journal-title":"Cell Signal"},{"key":"585_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cyto.2007.02.007","volume":"36","author":"O Livaditi","year":"2006","unstructured":"Livaditi O, Kotanidou A, Psarra A, Dimopoulou I, Sotiropoulou C, Augustatou K, et al. Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis. Cytokine. 2006;36:283\u201390.","journal-title":"Cytokine"},{"key":"585_CR18","doi-asserted-by":"publisher","first-page":"14752","DOI":"10.1038\/s41598-021-94224-2","volume":"11","author":"I Luna-Reyes","year":"2021","unstructured":"Luna-Reyes I, P\u00e9rez-Hern\u00e1ndez EG, Delgado-Coello B, \u00c1vila-Rodr\u00edguez M\u00c1, Mas-Oliva J. Peptide VSAK maintains tissue glucose uptake and attenuates pro-inflammatory responses caused by LPS in an experimental model of the systemic inflammatory response syndrome: a PET study. Sci Rep. 2021;11:14752.","journal-title":"Sci Rep"},{"key":"585_CR19","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1038\/s41598-018-32275-8","volume":"8","author":"H Matsumoto","year":"2018","unstructured":"Matsumoto H, Ogura H, Shimizu K, Ikeda M, Hirose T, Matsuura H, et al. The clinical importance of a cytokine network in the acute phase of sepsis. Sci Rep. 2018;8:13995.","journal-title":"Sci Rep"},{"key":"585_CR20","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.medin.2012.01.014","volume":"36","author":"V Miguel-Bayarri","year":"2012","unstructured":"Miguel-Bayarri V, Casanoves-Laparra EB, Pall\u00e1s-Beneyto L, Sancho-Chinesta S, Mart\u00edn-Osorio LF, Tormo-Caland\u00edn C, et al. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Intensive. 2012;36:556\u201362.","journal-title":"Med Intensive"},{"key":"585_CR21","first-page":"CD011811","volume":"4","author":"D Molano Franco","year":"2019","unstructured":"Molano Franco D, Arevalo-Rodriguez I, Roqu\u00e9 i Figuls M, Montero Oleas NG, Nuvials X, Zamora J. Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults. Cochrane Database Syst Rev. 2019;4:CD011811.","journal-title":"Cochrane Database Syst Rev"},{"key":"585_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/nu12030699","volume":"12","author":"A Nier","year":"2020","unstructured":"Nier A, Huber Y, Labenz C, Michel M, Bergheim I, Schattenberg JM. Adipokines and endotoxemia correlate with hepatic steatosis in non-alcoholic fatty liver disease (NAFLD). Nutrients. 2020;12:699.","journal-title":"Nutrients"},{"key":"585_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ags3.12194","volume":"2","author":"S Ono","year":"2018","unstructured":"Ono S, Tsujimoto H, Hiraki S, Aosasa S. Mechanisms of sepsis-induced immunosuppression and immunological modification therapies for sepsis. Ann Gastroenterol Surg. 2018;2:351\u20138.","journal-title":"Ann Gastroenterol Surg"},{"key":"585_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","volume":"32","author":"A Parlesak","year":"2000","unstructured":"Parlesak A, Sch\u00e4fer C, Sch\u00fctz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000;32:742\u20137.","journal-title":"J Hepatol"},{"key":"585_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111890","volume":"141","author":"EG P\u00e9rez-Hern\u00e1ndez","year":"2021","unstructured":"P\u00e9rez-Hern\u00e1ndez EG, Delgado-Coello B, Luna-Reyes I, Mas-Oliva J. New insights into lipopolysaccharide inactivation mechanisms in sepsis. Biomed Pharmacother. 2021;141: 111890.","journal-title":"Biomed Pharmacother"},{"key":"585_CR26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority\u2014a WHO resolution. N Engl J Med. 2017;377:414\u20137.","journal-title":"N Engl J Med"},{"key":"585_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200\u201311.","journal-title":"Lancet"},{"key":"585_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/165974","volume":"2013","author":"W Schulte","year":"2013","unstructured":"Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2014an updated view. Mediators Inflamm. 2013;2013: 165974.","journal-title":"Mediators Inflamm"},{"key":"585_CR29","doi-asserted-by":"publisher","first-page":"13726","DOI":"10.1074\/jbc.M609462200","volume":"282","author":"B Shao","year":"2007","unstructured":"Shao B, Lu M, Katz SC, Varley AW, Hardwick J, Rogers TE, et al. A host lipase detoxifies bacterial lipopolysaccharides in the liver and spleen. J Biol Chem. 2007;282:13726\u201335.","journal-title":"J Biol Chem"},{"key":"585_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"585_CR31","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/jn\/138.8.1452","volume":"138","author":"S Thuy","year":"2008","unstructured":"Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, K\u00f6nigsrainer A, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr. 2008;138:1452\u20135.","journal-title":"J Nutr"},{"key":"585_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T Van Der Poll","year":"2017","unstructured":"Van Der Poll T, Van De Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:407\u201320.","journal-title":"Nat Rev Immunol"},{"key":"585_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1172\/JCI10832","volume":"107","author":"ACE Vreugdenhil","year":"2001","unstructured":"Vreugdenhil ACE, Snoek AMP, Van\u2019T Veer C, Greve JWM, Buurman WA. LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL\/VLDL interaction. J Clin Invest. 2001;107:225\u201334.","journal-title":"J Clin Invest"},{"key":"585_CR34","unstructured":"WHO. Service delivery and safety: improving the prevention, diagnosis and clinical management of sepsis. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sepsis (2020). Accessed 23 May 2022."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00585-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-022-00585-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00585-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T20:24:13Z","timestamp":1671481453000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-022-00585-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1186\/s10020-022-00585-3","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"7 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by INCMNSZ\u2019s Research Ethics Committee (Reference number: 2252) and performed in accordance with the Declaration of Helsinki. Written informed consents were obtained from all participants before data and biological specimen collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.M\u2013O. is inventor on patent application PCT\/MX2014\/00087 related to this study, \u201cPeptides derived from the C-Terminal domain of CETPI as molecules blocking the lipopolysaccharide-induced effect in sepsis and septic shock\u201d, submitted to the World Intellectual Property Organization and held by Universidad Nacional Aut\u00f3noma de M\u00e9xico. I.L-R., E.G.P\u2013H., V.P-D., B.D-C., J.S\u2013O declare no competing conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}